Deferoxamine Mesylate for Injection 500mg Manufacturer, Supplier & Exporter
Taj Pharmaceuticals Ltd., based in Vapi, Gujarat, India, is a globally recognized manufacturer, supplier, and exporter of Deferoxamine Mesylate for Injection 500mg (Desfotaj). With decades of pharmaceutical expertise, cutting-edge technology, and strict compliance with WHO-GMP standards, we deliver safe, effective, and high-quality iron chelation therapy medicines trusted by healthcare providers worldwide.
About Deferoxamine Mesylate for Injection 500mg
Deferoxamine Mesylate Injection is a critical iron-chelating agent used in the treatment of chronic iron overload resulting from repeated blood transfusions. Patients with conditions such as thalassemia major, sickle cell anemia, and myelodysplastic syndromes are highly susceptible to excessive iron accumulation, which can damage the liver, heart, and endocrine system.
Deferoxamine binds to excess iron in the blood, forming a stable complex that is excreted via urine and stool. This process prevents iron-induced organ toxicity and ensures long-term patient safety.
Therapeutic Indications
Taj Pharma’s Deferoxamine Mesylate Injection 500mg is indicated for:
- Chronic iron overload due to frequent transfusions
- Thalassemia major and intermedia
- Sickle cell anemia with transfusion dependency
- Myelodysplastic syndromes (MDS)
- Secondary iron overload in other hematologic disorders
Deferoxamine Mesylate Injection Manufacturer in Vapi, Gujarat
Our state-of-the-art WHO-GMP manufacturing facility in Vapi ensures consistent quality, purity, and safety of each vial of Deferoxamine Mesylate Injection. With advanced quality control laboratories, automated sterile lines, and a strong regulatory framework, we maintain the highest international standards of production.
Every batch undergoes rigorous stability testing, sterility checks, and potency analysis, ensuring reliable performance in clinical use.
Deferoxamine Mesylate Injection Supplier in Mumbai, Maharashtra
Taj Pharma is a trusted Deferoxamine Mesylate Injection supplier in Mumbai, ensuring seamless PAN India distribution. With an efficient logistics network, we supply to:
- Government hospitals and tender supplies
- Private hospitals and specialty clinics
- Pharmaceutical distributors and wholesalers
- Retail pharmacy networks
We also guarantee best price offers in Mumbai and across India without compromising on quality.
Global Export of Deferoxamine Mesylate Injection
As a reputed exporter of Deferoxamine Mesylate Injection 500mg, Taj Pharma supplies to more than 40 countries worldwide, including:
- Africa – Nigeria, Kenya, Ethiopia, South Africa
- Middle East – Saudi Arabia, UAE, Qatar, Oman
- Latin America (LATAM) – Brazil, Mexico, Colombia, Peru
- Asia-Pacific – Vietnam, Philippines, Sri Lanka
- CIS Nations – Russia, Kazakhstan, Ukraine
Our products comply with global pharmacopeias (USP, BP, IP) and meet international regulatory requirements.
PCD Pharma Franchise for Deferoxamine Mesylate Injection
We provide PCD Pharma Franchise opportunities for Deferoxamine Mesylate for Injection across India. Benefits include:
- Exclusive distribution rights in assigned territories
- High-profit margins with assured product availability
- Comprehensive marketing and promotional support
- Access to our wider critical care injectables portfolio
This makes Taj Pharma a preferred partner for entrepreneurs and distributors looking to expand in the pharmaceutical sector.
Technical Specifications – Deferoxamine Mesylate Injection 500mg
- Product Name: Deferoxamine Mesylate for Injection
- Brand Name: Desfotaj
- Generic Name: Deferoxamine Mesylate
- Strength: 500mg per vial
- Dosage Form: Injection
- Route of Administration: Intravenous (IV), Intramuscular (IM), or Subcutaneous (SC)
- Manufacturer: Taj Pharmaceuticals Ltd., Vapi, Gujarat, India
- Therapeutic Class: Iron Chelating Agent
- Storage: Store below 25°C. Protect from light and moisture.
- Packing: Sterile vial with pack insert
- Dosage: As directed by a healthcare professional
Warnings and Precautions
- Administer only under the supervision of a qualified healthcare professional
- Avoid self-administration
- May cause dizziness, vision, or hearing disturbances – patients should avoid driving if affected
- Regular monitoring of serum iron levels, hearing, and vision is necessary
- Caution in pregnant and breastfeeding women – use only if prescribed
Possible Side Effects
Patients receiving Deferoxamine Mesylate Injection may experience:
- Pain, redness, or swelling at injection site
- Dizziness, fatigue, or headache
- Nausea, vomiting, or abdominal discomfort
- Rare but serious: visual or auditory changes, allergic reactions
Close medical supervision ensures safety and minimizes risks.
Deferoxamine Mesylate Injection PAN India Distribution
Taj Pharma ensures strong PAN India presence through a robust distribution network covering:
- Maharashtra: Mumbai, Pune, Nagpur
- Gujarat: Vapi, Ahmedabad, Surat, Vadodara
- Delhi NCR
- Tamil Nadu: Chennai, Coimbatore
- Karnataka: Bangalore, Mysore
- Punjab, Uttar Pradesh, West Bengal, Rajasthan
This nationwide accessibility guarantees that patients across India can obtain life-saving iron chelation therapy.
Why Choose Taj Pharma for Deferoxamine Mesylate Injection?
✔ WHO-GMP Certified facilities
✔ Best price in Mumbai and PAN India supply
✔ Trusted exporter to Africa, Middle East, LATAM, and Asia-Pacific
✔ Strong regulatory compliance with global standards
✔ PCD Pharma Franchise support with promotional materials
✔ Proven track record as one of India’s top critical care injection manufacturers
Taj Pharmaceuticals Ltd. is a leading manufacturer, supplier, and exporter of Deferoxamine Mesylate for Injection 500mg (Desfotaj) from Vapi, Gujarat, India. With a focus on quality, affordability, and global healthcare access, Taj Pharma has emerged as the #1 choice for hospitals, distributors, and PCD Pharma partners across India and worldwide.
For reliable supply of Deferoxamine Mesylate Injection, whether for domestic distribution, international export, or franchise partnerships, Taj Pharma stands as the most trusted partner in the pharmaceutical industry.
